Hunan Jingfeng Pharmaceutical Co.,Ltd.
public_traded
Hunan Jingfeng Pharmaceutical Co.,Ltd. is publicly traded on SHZ under ticker 000908.SZ.
Hunan Jingfeng Pharmaceutical Co.,Ltd. manufactures and sells chemical drugs and biological agents in China. The company's principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmology and API products, as well as engages in the research and development of anti-tumor, cancer, and cardiovascular drugs; and provides skin care products. The company was founded in 2003 and is headquartered in Shanghai, China.